Navigating Insurance Coverage for Prescription Digital Therapeutics

Mahsa Salsabili, PharmD, PhD, addresses the challenges surrounding insurance approval and the limited announcements regarding coverage for prescription digital therapeutics, while exploring various reimbursement models, such as value-based contracts and outcome-based rebates.

EP: 1.Overview of Prescription Digital Therapeutics and Impact on Clinical Practice

EP: 2.Bridging Care Gaps with Prescription Digital Therapeutics

EP: 3.Harnessing Prescription Drug Therapeutics as Monotherapy and Adjunct Therapy

EP: 4.Assessing the Cost-Effectiveness of Prescription Digital Therapeutics

EP: 5.FDA Approval Pathway for Prescription Digital Therapeutics

Now Viewing

EP: 6.Navigating Insurance Coverage for Prescription Digital Therapeutics

EP: 7.Prescribing Prescription Drug Therapeutics: Factors for Providers and Payers to Consider

EP: 8.Risk and Value-Based Contracting for Prescription Drug Therapeutics and Manufacturer’s Support in Utilization

EP: 9.PDTs Represent a Shift in How Treatment Is Delivered

Recent Videos

Related Content

---

Patients Express Concerns Over Costs, Risks of Gene Therapies for Sickle Cell Disease

Laura Joszt, MA

August 23rd 2025

Article

Read More

---

A Single CRISPR Treatment Could Replace a Lifetime of Daily Treatment in Hereditary Angioedema

Laura Joszt, MA

August 23rd 2025

Article

Read More

---

New Chronic GVHD Treatments Show Promise, but Long-Term Outcomes Are Not Well Understood

Laura Joszt, MA

August 23rd 2025

Article

Read More

---

GVHD Cannot Be Wholly Prevented, so Effective Treatments Are Needed, Says Dr. Daniel Wolff

Laura Joszt, MA

August 23rd 2025

Article

Read More

---

Evolving Role of Statins in Managing CV Risk in HIV | ID Week 2024

Peter Wehrwein, Managing Editor;Laura Joszt, MA

August 23rd 2025

Article

Read More

---

Pulmonary Hypertension Diagnosis on Top of ILD Subsequently Increases Healthcare Use, Costs

Laura Joszt, MA

August 23rd 2025

Article

Read More

Related Content

---

Patients Express Concerns Over Costs, Risks of Gene Therapies for Sickle Cell Disease

Laura Joszt, MA

August 23rd 2025

Article

Read More

---

A Single CRISPR Treatment Could Replace a Lifetime of Daily Treatment in Hereditary Angioedema

Laura Joszt, MA

August 23rd 2025

Article

Read More

---

New Chronic GVHD Treatments Show Promise, but Long-Term Outcomes Are Not Well Understood

Laura Joszt, MA

August 23rd 2025

Article

Read More

---

GVHD Cannot Be Wholly Prevented, so Effective Treatments Are Needed, Says Dr. Daniel Wolff

Laura Joszt, MA

August 23rd 2025

Article

Read More

---

Evolving Role of Statins in Managing CV Risk in HIV | ID Week 2024

Peter Wehrwein, Managing Editor;Laura Joszt, MA

August 23rd 2025

Article

Read More

---

Pulmonary Hypertension Diagnosis on Top of ILD Subsequently Increases Healthcare Use, Costs

Laura Joszt, MA

August 23rd 2025

Article

Read More